Sun India Medicines Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 18-07-2024
- Paid Up Capital ₹ 3.34 M
as on 18-07-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 289.24%
(FY 2022)
- Profit 338.98%
(FY 2022)
- Ebitda 102.94%
(FY 2022)
- Net Worth 51.92%
(FY 2022)
- Total Assets -13.60%
(FY 2022)
About Sun India Medicines
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.34 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Agarwal and Kanika Garg serve as directors at the Company.
- CIN/LLPIN
U74899DL1989PTC038208
- Company No.
038208
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sun India Medicines?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Agarwal  | Director | 13-Oct-1989 | Current |
| Kanika Garg | Director | 06-May-2021 | Current |
Financial Performance of Sun India Medicines.
Sun India Medicines Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 289.24% increase. The company also saw a substantial improvement in profitability, with a 338.98% increase in profit. The company's net worth Soared by an impressive increase of 51.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sun India Medicines?
In 2022, Sun India Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Maharaja Agarsain Educational Services Private LimitedActive 18 years 4 months
Manish Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sun India Medicines?
Unlock and access historical data on people associated with Sun India Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun India Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun India Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
